2024
|
P/S
|
Facial cream; Cosmetic milks; Non-medicated skin care preparations, namely milky lotions; Cosmeti... |
2023
|
P/S
|
Antiallergic medicines; antidiarrheal medicines; medicines for the treatment of gastrointestinal ... |
|
P/S
|
Medicines for human purposes; Reagents for use in diagnostic tests [for medical purposes]; Medici... |
2021
|
Invention
|
Quinazoline derivatives useful as selective hdac6 inhibitors.
Provided herein is a compound of F... |
2019
|
Invention
|
Method for treating a neurodegenerative disorder. The invention provides a method for treating a ... |
2018
|
Invention
|
Histone deacetylases (hdacs) inhibitors. Histone deacetylases (HDACs) inhibitors are disclosed ac... |
2016
|
Invention
|
Compounds with (1e, 6e)-1,7-bis-(3,4-dimethoxyphenyl)-4-4-distributed-hepta-1,6-diene-3,5-dione s... |
2015
|
Invention
|
Histone deacetylases (hdacs) inhibitors. Histone deacetylases inhibitors (HDACIs) and methods for... |
|
Invention
|
Compounds with (1 e, 6e)-1,7-bis-(3,4-dimethoxyphenyi)-4,4-disubstituted-hepta-1,6-diene-3,5-dion... |
2013
|
Invention
|
Compounds with (1e, 6e)-1,7-bis-(3,4-dimethoxyphenyl)-4,4-disubstituted-hepta-1,6-diene-3,5-dione... |
|
Invention
|
Indolin-2-one derivatives as protein kinase inhibitors. A novel class of indoline-2-one derivativ... |
|
Invention
|
Multifunctional quinoline derivatives as anti-neurodegenerative agents. Novel quinoline derivativ... |
|
Invention
|
Cyclopropanecarboxylate esters of purine analogues. Cyclopropanecarboxylate esters of purine anal... |
|
Invention
|
Histone deacetylases (hdacs) inhibitors. Histone deacetylases inhibitors (HDACIs) and composition... |
2012
|
Invention
|
Compounds with (1 e, 6e)-1,7-bis-(3,4-dimethoxyphenyl)-4,4-disubstituted-hepta-1,6-diene-3,5-dion... |
2010
|
Invention
|
Compounds with (substituted phenyl)-propenal moiety, their derivatives, biological activity, and ... |